Myocardial protective effects of nicorandil,an opener of potassium channels on senile rat heart

Abstract

The purpose of this study was to investigate the cardio-protective effects of nicorandil, an opener of potassium channels, on senile rat hearts from ischemic reperfusion injury.

A modified working model of isolated perfused hearts of senile rats was used. After isolation, the hearts underwent 60 min of global hypothermic ischemia treatment, followed by 30 min of reperfusion. These hearts were distributed into three groups, each receiving different cardioplegic solutions: (1) St. Thomas’ solution (Group S), (2) 100 μmol/L nicorandil (Group N), (3) St. Thomas’ solution combined with 100 μmol/L nicorandil (Group S+N). The pre- and post-ischemic myocardial function were assessed by the percentage recovery of the heart rate (HR), ±dp/dt_max (maximal rate of change of left ventricular pressure) and cardiac output (CO). Upon reperfusion, the cardioplegic solution was collected from the coronary sinus and tested for lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB) activity.

During 30 min of reperfusion, the percentage recovery of HR, +dp/dt and left ventricular stroke work (LVSW) were significantly higher in Group S+N than in Group S and Group N (p < 0.05). The percentage of recovery in CO was higher in Group N and Group S+N than in Group S. The electrical activities arresting time (EAT) and mechanical activities arresting time (MAT) were longer in Group N than in Group S and Group N+S(p < 0.01). There were no statistical significance between Group S and Group N+ S(p > 0.05). There were no significant differences in the levels of LDH and CK-MB. Electron microscopic examination revealed better preservation of the ultra-structures of the myocardial tissue in Group N+S than the other two groups.

These results indicate that nicorandil combined with St. Thomas’ solution can improve the left ventricular function of the post-ischemic senile rat and offer a better myocardial protective effect on the ischemic senile myocardium.

Get full access to this article

View all access options for this article.

References

Willems L , Garnham B , Headrick JP. Aging-related changes in myocardial purine metabolism and ischemic tolerance . Exp Gerontol 2003; 38: 1169-1177 .

Bartling B , Friedrich I , Silber RE. Ischemic preconditioning is not cardioprotective in senescent human myocardium . Ann Thorac Surg 2003; 76: 105-111 .

Gomma AH , Purcell HJ , Fox KM. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil . Drugs 2001; 61: 1705-1710 .

Gross GJ , Auchampach JA. Role of ATP-dependent potassium channels in myocardial ischaemia . Cardiovasc Res 1992; 26: 1011-1016 .

Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning . Basic Res Cardiol 1995; 90: 85-88 .

Jayawant M , Stephenson ER Jr , Damiano RJ Jr et al. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas’ Hospital solution during prolonged ischemia . J Thorac Cardiovasc Surg 1998; 116: 131-138 .

Damiano RJ Jr , Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternative to traditional hyperkalemic cardioplegia ? J Card Surg 1994; 9: 517-525 .

Fremes SE , Weisel RD , Mickle DA et al. Myocardial metabolism and ventricular function following cold potassium cardioplegia . J Thorac Cardiovasc Surg 1985; 89: 531-546 .

Garnier-Raveaud S , Faury G , Mazenot C et al. Highly protective effects of chronic oral administration of nicorandil on the heart of ageing rats . Clin Exp Pharmacol Physiol 2002; 29: 441-448 .

10.

Li Y , Iguchi A , Tsuru Y et al. Nicorandil pretreatment and improved myocardial protection during cold blood cardioplegia . Jpn J Thorac Cardiovasc Surg 2000; 48: 24-29 .

11.

Hayashi Y , Sawa Y , Ohtake S. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting . J Cardiovasc Pharmacol 2001; 38: 21-28 .

12.

Lawton JS , Hsia PW , McClain LC et al. Myocardial oxygen consumption in the rabbit heart after ischemia: hyperpolarized arrest with pinacidil versus depolarized hyperkalemic arrest . Circulation 1997; 91: II-247-II-252 .

13.

Jayawant AM , Lawton JS , Hsia PW et al. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers . Circulation 1997; 96: II-240-II-246 .

14.

Obata T. Adenosine production and its role in protection against ischemic and reperfusion injury of the myocardium . Nippon Yakurigaka Zasshi 2002; 19: 273-279 .

15.

Lawton JS , Sepic JD , Allen CT , Hsia PW , Damiano RJ Jr. Myocardial protection with potassium-channel openers is as effective as St. Thomas’ solution in the rabbit heart . Ann Thorac Surg 1996; 62: 31-38 .

16.

Steensrud T , Nordhaug D , Husnes KV et al. Replacing potassium with nicorandil in cold St. Thomas’ Hospital cardioplegia improves preservation of energetics and function in pig hearts . Ann Thorac Surg 2004; 77: 1391-1437 .

17.

Saeed M , Watzingor N , Krombach GA et al. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model . Radiology 2002; 224: 830-837 .

18.

Maskal SL , Cohen NM , Hsia PW et al. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim . J Thorac Cardiovasc Surg 1995; 110: 1083-1095 .

19.

Mccully JD , Tsukube T , Atake K et al. Myocardial cytosolic calcium accumulation during ischemia-reperfusion: the effects of aging and cardioplegia . J Card Surg 1994; 9: 449-452 .

20.

21.

Cohen NM , Wise RM , Wechsler AS et al. Elective cardiac arrest with a hyperpolarizing adenosine tri-phosphate-sensitive potassium channel opener . A novel form of myocardial protection? J Thorac Cardiovasc Surg 1999; 106: 317-328 .